Amryt Pharma plc

Amryt Pharma plcverified

AMYT

Price:

$14.7

Market Cap:

$0

Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2020-07-08

Stock Exchange

NASDAQ

Ticker

AMYT

The Current Ratio as of May 2024 (TTM) for Amryt Pharma plc (AMYT) is 1.80

According to Amryt Pharma plc’s latest financial reports and current stock price. The company's current Current Ratio is 1.80. This represents a change of 116.25% compared to the average of 0.83 of the last 4 quarters.

Amryt Pharma plc (AMYT) Historical Current Ratio (quarterly & annually)

How has AMYT Current Ratio performed in the past?

The mean historical Current Ratio of Amryt Pharma plc over the last ten years is 9.64. The current 1.80 Current Ratio has changed 1.77% with respect to the historical average. Over the past ten years (40 quarters), AMYT's Current Ratio was at its highest in in the March 2013 quarter at 46.97. The Current Ratio was at its lowest in in the June 2007 quarter at 0.

Quarterly (TTM)
Annual

Average

9.64

Median

1.90

Minimum

1.33

Maximum

46.97

Amryt Pharma plc (AMYT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Amryt Pharma plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.85%

Maximum Annual Current Ratio = 46.97

Minimum Annual Increase = -97.16%

Minimum Annual Current Ratio = 1.33

Quarterly (TTM)
Annual
YearCurrent RatioChange
20211.80-10.40%
20202.0136.54%
20191.47-8.27%
20181.60-40.38%
20172.69-17.65%
20163.26-90.31%
201533.662.43%
20141.33-97.16%
201346.972.85%
20121.59759.25%

Amryt Pharma plc (AMYT) Average Current Ratio

How has AMYT Current Ratio performed in the past?

The current Current Ratio of Amryt Pharma plc (AMYT) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.76

5-year avg

1.91

10-year avg

9.64

Amryt Pharma plc (AMYT) Current Ratio vs. Peers

How is AMYT’s Current Ratio compared to its peers?

Amryt Pharma plc’s Current Ratio is less than Universe Pharmaceuticals INC (2.68), less than Regencell Bioscience Holdings Limited (19.15), greater than Indigenous Bloom Hemp Corp. (0.05), less than Eagle Pharmaceuticals, Inc. (2.16), greater than Sangui Biotech International, Inc. (0.05), less than Qilian International Holding Group Limited (5.18), greater than IM Cannabis Corp. (0.65), less than GelStat Corporation (0), greater than Pacira BioSciences, Inc. (0.11), less than Collegium Pharmaceutical, Inc. (5.81), greater than Prestige Consumer Healthcare Inc. (1.21), less than Incannex Healthcare Limited (3.20), less than Phibro Animal Health Corporation (5.70), less than Shuttle Pharmaceuticals Holdings, Inc. (3.16), less than Mallinckrodt plc (2.91), greater than Organogenesis Holdings Inc. (0.57), less than Lucy Scientific Discovery Inc. (2.74), greater than Alimera Sciences, Inc. (0.38), less than null (2.62),

Build a custom stock screener for Amryt Pharma plc (AMYT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amryt Pharma plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amryt Pharma plc (AMYT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amryt Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Amryt Pharma plc's Current Ratio?

How is the Current Ratio calculated for Amryt Pharma plc (AMYT)?

What is the highest Current Ratio for Amryt Pharma plc (AMYT)?

What is the 3-year average Current Ratio for Amryt Pharma plc (AMYT)?

What is the 5-year average Current Ratio for Amryt Pharma plc (AMYT)?

How does the current Current Ratio for Amryt Pharma plc (AMYT) compare to its historical average?